Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Ryght logo — The Insight Platform for BioPharma

Ryght

The Insight Platform for BioPharma

Founded 2023 United States Laguna Beach, United States 19 employees Seed Biopharma, Health Care +1

General Information

Company Name Ryght
Founded Year 2023
Location United States Laguna Beach, United States
Employees 19
Industries Biopharma, Health Care, Platforms
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with Ryght. To contact Ryght, visit ryght.ai.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Ryght

Synthetica Bio is a disruptive player in the Biopharma and Biotechnology industries, aiming to revolutionize the sector with their Insight Platform for BioPharma. Their enterprise-grade Generative AI platform, Ryght, is tailored to meet the specific needs of life science professionals, offering capabilities that include document creation, surfacing the latest research, revenue growth, and expediting drug market entry.

The startup, founded in 2023, has received a Seed Round investment as of 27 June 2023. The impressive roster of investors includes AIX Ventures, Virtue, Page One Ventures, and Top Harvest Capital, signaling confidence and interest from prominent players in the investment landscape.

Synthetica Bio's platform holds the potential to significantly impact the efficiency and output of the bio-pharmaceutical realm, and the support garnered from respected investors underscores the promising nature of the venture.

Taxonomy: Generative AI, BioPharma, Life Science, Enterprise-grade platform, Document creation, Research surfacing, Revenue growth, Drug development, Market acceleration

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round Undisclosed 1
Iaso Ventures
Iaso Ventures
01 Nov 2023

Ryght Alternatives & Competitors

Ryght vs
Sinogen Biopharma
Sinogen Biopharma

Pioneering the path for Chinese biotech to reach the U.S. pharmaceutical landscape, fostering the de...

Series B
Biopharma, Biotechnology
Ryght vs
MAX BioPharma, Inc.
MAX BioPharma, Inc. United States

Pioneering new treatments for severe and life-threatening illnesses through innovative small molecul...

12 employees
Biopharma, Biotechnology

FAQ About Ryght

The Insight Platform for BioPharma
Ryght was founded in 2023.
Ryght is headquartered in Laguna Beach, United States.
Ryght operates in Biopharma, Health Care and Platforms. Its work centres on Generative AI, BioPharma, Life Science and Enterprise-grade platform.
Ryght has approximately 19 employees.
Ryght has completed 1 funding round. The latest funding stage is Seed.
Top alternatives and competitors to Ryght include Sinogen Biopharma, MAX BioPharma, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Ryght and Sinogen Biopharma are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Ryght, https://bouncewatch.com/company/synthetica-bio, updated 14 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes